DBV Technologies | DBVT - Eps Gewinn Pro Aktie

Aktienkurs
22.20
Täglich Wechseln
-0.59 -2.59%
Monatlich
4.42%
Jährlich
395.95%
Q1 Prognose
20.46




Eps Veränderung Datum
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amarin USD 0.08 0.11 2025-09
BioCryst Pharmaceuticals USD -0.13 0.06 2024-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
DBV Technologies USD -0.24 1.31 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Galectin Therapeutics USD -0.2 0.01 2024-06
Halozyme Therapeutics USD -0.24 1.96 2025-12
Incyte USD 1.8 0.46 2025-12
Insmed USD -1.54 0.21 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
United Therapeutics USD 7.7 0.54 2025-12